Researchers at Wayne State University and the Barbara Ann Karmanos Cancer Institute have developed a chemical imaging probe that resists the breakdown of certain compounds in the body, giving doctors ...
Researchers led by Keyi Li from the General Hospital of Northern Theater Command in Shenyang, along with international collaborators, detail significant advances in the identification and application ...
Transrectal ultrasound-guided biopsy is a widely accepted procedure in prostate cancer diagnosis, although little is known about the effects on the detection rate of different types of ultrasound ...
A transrectal ultrasound (TRUS) of the prostate may also be called a prostate sonogram or endorectal ultrasound. A doctor usually performs a TRUS to help diagnose prostate cancer or detect prostate ...
SALT LAKE CITY—Molecular imaging has a powerful new weapon in the fight against prostate cancer. Research introduced at SNM's 57th Annual Meeting demonstrates how a novel peptide-targeted imaging ...
Prostate cancer is one of the most common cancers and the second leading cause of cancer-related death in men in the U.S. The American Cancer Society estimates there were 192,000 new cases last year ...
A cohort compassionate-use program with cabazitaxel plus prednisone for patients with metastatic castration-resistant prostate cancer: Interim results. This is an ASCO Meeting Abstract from the 2012 ...
Between 1999 and 2009 in the United Kingdom, 82,429 men between 50 and 69 years of age received a prostate-specific antigen (PSA) test. Localized prostate cancer was diagnosed in 2664 men. Of these ...